| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $145.8M | +14.3% |
| Cost of Revenue | $57.0M | -2.1% |
| Gross Profit | $88.8M | +28.0% |
| R&D Expense | $46.1M | +9.5% |
| SG&A Expense | $28.9M | -0.6% |
| Operating Income | -$23.6M | +49.0% |
| Pre-tax Income | -$25.5M | +47.4% |
| Income Tax | $84K | +1300.0% |
| Net Income | -$25.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.2M | -36.3% |
| Short-term Investments | $22.2M | +142.9% |
| Accounts Receivable | $3.5M | +90.2% |
| Current Assets | $65.7M | -0.1% |
| Total Assets | $191.8M | +13.8% |
| Current Liabilities | $61.6M | +3.0% |
| Total Liabilities | $108.6M | +19.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.5M | +88.3% |
| Capital Expenditures | $4.7M | +174.3% |
| Investing Cash Flow | -$25.3M | -313.3% |
| Financing Cash Flow | -$14.8M | -165.0% |
| Free Cash Flow | $18.9M | +74.6% |
| +47.2% |
| EPS (Basic) | -$0.46 | +58.6% |
| EPS (Diluted) | -$0.46 | +58.6% |
| Stockholders' Equity |
| $83.2M |
| +7.2% |